Mesenchymal stem cells (MSCs) as skeletal therapeutics - an update

Area of Science:

• Regenerative Medicine
• Orthopedics
• Stem Cell Biology

Background:

• Mesenchymal stem cells (MSCs) are investigated for treating bone degenerative diseases and repairing bone tissue.
• Both autologous and allogeneic MSC transplantation are explored for skeletal applications.

Purpose of the Study:

• To review clinical therapeutic options for MSCs in skeletal diseases and tissue regeneration.
• To discuss preclinical evidence, clinical studies, and post-transplant mechanisms of MSCs.
• To address challenges and future directions for MSCs in skeletal repair.

Main Methods:

• Review of preclinical and clinical studies on MSCs for skeletal disorders.
• Analysis of MSC transplantation methods (alone or scaffold-loaded).
• Discussion of therapeutic mechanisms and challenges.

Main Results:

• Evidence suggests promising clinical outcomes for MSCs in skeletal diseases and tissue repair.
• Various transplantation strategies and supportive scaffolds are utilized.
• MSC mechanisms of action and challenges in clinical application are discussed.

Conclusions:

• MSCs offer potential for treating skeletal diseases and regenerating bone.
• Further research and development are needed to overcome challenges for widespread clinical use.
• MSC therapy for skeletal disorders is an evolving field with future potential.